Radcliffe Capital Management, L.P. - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 62 filers reported holding BIOTECH ACQUISITION COMPANY in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$2,049,775
+1.8%
202,9500.0%0.06%
+32.7%
Q3 2022$2,014,000
+0.2%
202,9500.0%0.05%
+6.5%
Q2 2022$2,009,000
+0.4%
202,9500.0%0.05%
+2.2%
Q1 2022$2,001,000
+0.2%
202,9500.0%0.04%
-13.5%
Q4 2021$1,997,000
+1.0%
202,9500.0%0.05%
-10.3%
Q3 2021$1,977,000
+0.7%
202,9500.0%0.06%
-4.9%
Q2 2021$1,963,000202,9500.06%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q4 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BIOTECH ACQUISITION COMPANY shareholders